Neophar Pharmaceuticals Private Limited

Founded in 2023 and headquartered in Delhi, India.

2023 | Delhi (India) | Active
Last Updated: December 11, 2024

Neophar Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 4 Months

About Neophar Pharmaceuticals

Neophar Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 October 2023 (One year and four months 1 days old ). Its registered office is in Delhi, India.

The Company is engaged in the Paper Industry.

The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Ruby Rani and Manish Kumar serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U21001DL2023PTC421633

  • Company No.

    421633

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    19 Oct 2023

  • Date of AGM

    -

  • Date of Balance Sheet

    -

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Paper

Who are the key members and board of directors at Neophar Pharmaceuticals?

Board Members (2)

Name Designation Appointment Date Status
Ruby Rani Country flag representing In Director 19-Oct-2023 Current
Manish Kumar Country flag representing In Director 19-Oct-2023 Current

Financial Performance of Neophar Pharmaceuticals.

Enhance accessibility to Neophar Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Neophar Pharmaceuticals?

Unlock access to Neophar Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Neophar Pharmaceuticals?

Unlock and access historical data on people associated with Neophar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neophar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neophar Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Neophar Pharmaceuticals

Recent activity within the organization

  • Director Appointment

    Ruby Rani was appointed as a Director was appointed as a Director on 19 Oct 2023 & has been associated with this company since 1 year 4 months .

    19 Oct 2023

  • Director Appointment

    Manish Kumar was appointed as a Director was appointed as a Director on 19 Oct 2023 & has been associated with this company since 1 year 4 months .

    19 Oct 2023

  • Company Incorporation

    Neophar Pharmaceuticals Private Limited was registered on 19 Oct 2023 with Roc Delhi & aged 1 year 4 months as per MCA records.

    19 Oct 2023

Frequently asked questions

  • Neophar Pharmaceuticals Private Limited was incorporated on 19 Oct 2023.

  • The authorized share capital of Neophar Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Neophar Pharmaceuticals Private Limited.

    • Ruby Rani
    • Manish Kumar
  • As per Ministry of Corporate Affairs (Mca), the registered address of Neophar Pharmaceuticals Private Limited is Plot No 221 Ground Floor Pkt H Sector-1 Bawana, India, Delhi, 110039.

  • The corporate identification number (CIN) of Neophar Pharmaceuticals Private Limited is U21001DL2023PTC421633 and the company number is 421633 as per Ministry of Corporate Affairs (MCA).